Recombinant Chromobacterium violaceum Protein CrcB homolog (crcB)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for fulfillment according to your requirements.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its incorporation.
Synonyms
crcB; CV_1940; Putative fluoride ion transporter CrcB
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-126
Protein Length
full length protein
Species
Chromobacterium violaceum (strain ATCC 12472 / DSM 30191 / JCM 1249 / NBRC 12614 / NCIMB 9131 / NCTC 9757)
Target Names
crcB
Target Protein Sequence
MWKSILAIAIGAAAGALLRWFLGLRLNSLFPSLPPGTLAANLVGGYIIGVAVALFADMPM LSPLWRLLIITGFCGGLTTFSTFSAEVVDLLRQGQLQPAFAAIAVHVSGSLLMTMAGIAS WQWLRR
Uniprot No.

Target Background

Function

Crucial for reducing intracellular fluoride concentration, thereby mitigating its toxicity.

Database Links

KEGG: cvi:CV_1940

STRING: 243365.CV_1940

Protein Families
CrcB (TC 9.B.71) family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the genomic context of the crcB homolog in Chromobacterium violaceum?

The crcB homolog in C. violaceum is part of the organism's genomic architecture that includes several membrane transport systems. Similar to other characterized bacterial systems, the crcB gene typically exists in an operon structure that may include related fluoride resistance genes. In C. violaceum ATCC 12472, the genome contains multiple genes encoding membrane transport proteins, including at least 15 genes for MarR family transcription factors that regulate various efflux systems . When investigating crcB, researchers should examine its genomic neighborhood for potential co-regulated genes, especially those involved in ion transport or stress responses, similar to how the emrCAB operon is regulated by emrR in this organism .

How does Chromobacterium violaceum's natural environment relate to crcB expression?

C. violaceum is a Gram-negative free-living, saprophytic bacterium found in waters and soils of tropical and subtropical regions . The natural habitat of C. violaceum likely contains variable levels of fluoride ions, which would influence crcB expression. The most effective methodology to investigate environmental regulation includes:

  • Collecting soil and water samples from C. violaceum natural habitats

  • Measuring fluoride concentrations using ion-selective electrodes

  • Culturing C. violaceum under controlled laboratory conditions with varying fluoride concentrations

  • Quantifying crcB expression levels using RT-qPCR in response to these environmental conditions

This approach helps establish the ecological relevance of crcB function and mirrors methods used to study other environmentally responsive genes in C. violaceum, such as those regulated by the quorum-sensing system .

What expression systems are optimal for producing recombinant C. violaceum CrcB protein?

When expressing the C. violaceum crcB homolog, researchers should consider the following methodological approach:

Expression SystemAdvantagesLimitationsRecommended Tags
E. coli BL21(DE3)High yield, established protocolsPotential toxicityC-terminal His6
E. coli C43(DE3)Better for membrane proteinsLower yieldN-terminal His6-MBP
C. violaceum itselfNative processingTechnical challengesFLAG tag
Cell-free expressionAvoids toxicity issuesExpensiveHis6-SUMO

For optimal results, use a dual approach:

  • Express in E. coli C43(DE3) with an N-terminal His6-MBP fusion to improve solubility and reduce toxicity

  • Implement a tightly controlled inducible promoter system (e.g., T7-lac or araBAD)

  • Culture at lower temperatures (16-20°C) after induction

  • Include appropriate membrane-mimicking detergents during purification

This methodology follows established protocols for expressing challenging membrane proteins while addressing the specific characteristics of C. violaceum proteins, similar to approaches used for studying other transport proteins in this organism .

How should fluoride transport activity of CrcB be measured in experimental settings?

Measuring fluoride transport by recombinant CrcB requires a multi-faceted approach:

  • Fluoride-Specific Electrode Measurements:

    • Reconstitute purified CrcB in proteoliposomes

    • Monitor fluoride ion movement across the membrane under various conditions

    • Compare with known fluoride transporters as positive controls

  • Fluorescence-Based Assays:

    • Use pH-sensitive or ion-sensitive fluorescent probes

    • Monitor real-time fluoride transport in living cells expressing CrcB

    • Quantify transport kinetics under varying substrate concentrations

  • Growth Inhibition Assays:

    • Culture C. violaceum wild-type and crcB knockout strains in media with increasing fluoride concentrations

    • Determine minimum inhibitory concentrations

    • Complement knockout strains with recombinant crcB to confirm phenotype

This comprehensive methodology allows for both in vitro and in vivo assessment of transport activity, providing more robust data than single-approach methods, similar to the approaches used to study EmrCAB efflux pump function in C. violaceum .

How might CrcB function intersect with C. violaceum pathogenesis?

Although C. violaceum is primarily an environmental bacterium, it can cause opportunistic infections with rapid dissemination and high mortality . The potential role of CrcB in pathogenesis should be investigated through:

  • Infection Models:

    • Compare virulence of wild-type and crcB mutant strains in appropriate animal models

    • Evaluate bacterial burden in tissues with varying fluoride levels

    • Assess survival rates and disease progression

  • Host-Pathogen Interface Analysis:

    • Examine crcB expression during infection using transcriptomics

    • Determine if host defense mechanisms involve fluoride as an antimicrobial strategy

    • Investigate potential cross-talk between CrcB and virulence factor regulation

  • Structural and Functional Correlations:

    • Identify CrcB structural motifs that may have dual roles in ion transport and virulence

    • Develop targeted inhibitors to test effects on both fluoride resistance and pathogenicity

    • Investigate protein-protein interactions between CrcB and known virulence regulators

This approach parallels the investigation of other membrane systems in C. violaceum, such as the relationship between the EmrCAB efflux pump and virulence-associated phenotypes like violacein production .

What is the relationship between CrcB and quorum sensing in C. violaceum?

C. violaceum utilizes an N-acyl-L-homoserine lactone (AHL)-based quorum-sensing system CviI/CviR that activates violacein synthesis . Investigating potential relationships between CrcB and quorum sensing requires:

  • Expression Analysis:

    • Perform transcriptome analysis of crcB expression in quorum sensing mutants (ΔcviI, ΔcviR)

    • Monitor crcB expression throughout growth phases when quorum sensing is active

    • Use reporter gene fusions to visualize crcB expression patterns in colonies

  • Functional Intersection Testing:

    • Create double mutants (ΔcrcB/ΔcviI, ΔcrcB/ΔcviR) and assess phenotypes

    • Determine if CrcB affects extracellular accumulation of AHLs using biosensor strains

    • Measure violacein production in crcB mutants under various fluoride concentrations

  • Biochemical Interaction Studies:

    • Perform pull-down assays to identify potential interactions between CrcB and quorum sensing components

    • Use fluorescence resonance energy transfer (FRET) to detect proximity of proteins in living cells

    • Conduct electrophoretic mobility shift assays (EMSAs) to identify potential DNA-binding regulatory proteins that control both systems

This methodology parallels the approach used to demonstrate how the EmrCAB efflux pump affects quorum sensing by influencing the accumulation of AHL signaling molecules in C. violaceum .

How can researchers address inconsistent phenotypes in crcB mutant strains?

When working with crcB mutants in C. violaceum, researchers may encounter variable phenotypes due to several factors:

Potential IssueDiagnostic ApproachResolution Strategy
Compensatory mutationsWhole genome sequencing of mutant strainsCreate multiple independent mutants
Redundant transport systemsTranscriptome analysis of knockout strainsGenerate multiple gene knockouts
Strain background effectsCompare phenotypes across different C. violaceum isolatesUse isogenic strains for all comparisons
Environmental variablesStandardize growth conditions and media compositionImplement rigorous protocol standardization

This troubleshooting approach is critical as C. violaceum, like other bacteria, often has redundant systems that can mask phenotypes when single genes are deleted. For example, deletion of the emrCAB operon in wild-type C. violaceum showed no effect on antibiotic susceptibility, suggesting functional redundancy with other efflux systems .

What are the key controls needed when studying CrcB-mediated fluoride transport?

Robust experimental design for CrcB functional studies requires comprehensive controls:

  • Genetic Controls:

    • Wild-type C. violaceum strain

    • crcB clean deletion mutant

    • Complemented mutant with wild-type crcB

    • Mutant complemented with catalytically inactive crcB (point mutations in conserved residues)

  • Biochemical Controls:

    • Membrane preparations from cells not expressing CrcB

    • Liposomes without reconstituted protein

    • Ion specificity controls (testing transport of chloride, bromide, etc.)

    • Inhibitor controls (using known fluoride transport inhibitors)

  • Experimental Design Controls:

    • Temperature controls (maintaining consistent conditions)

    • pH controls (fluoride transport is often pH-dependent)

    • Measurements in the absence of ion gradients

    • Time-course measurements to establish transport kinetics

This control framework ensures reliable data interpretation and addresses potential artifacts, similar to the careful approaches used to validate the role of EmrCAB in nalidixic acid resistance in C. violaceum .

How might structural studies of CrcB inform development of inhibitors against C. violaceum?

Structural characterization of CrcB presents significant challenges and opportunities:

  • Advanced Structural Methods:

    • Cryo-electron microscopy of purified CrcB in nanodiscs

    • X-ray crystallography of stabilized CrcB variants

    • Solid-state NMR of CrcB in native-like membrane environments

    • Molecular dynamics simulations based on homology models

  • Structure-Function Analysis:

    • Site-directed mutagenesis of putative channel-forming residues

    • Examination of ion selectivity determinants

    • Identification of gating mechanisms and regulatory sites

  • Inhibitor Development Pipeline:

    • In silico screening against structural models

    • Fragment-based drug discovery approaches

    • Structure-activity relationship studies of lead compounds

    • Validation in both biochemical assays and infection models

This systematic approach to CrcB structure would complement existing research on C. violaceum membrane proteins and potentially identify new targets for treating this opportunistic pathogen, which is often resistant to conventional antibiotics .

What emerging technologies could enhance our understanding of CrcB function in C. violaceum?

Several cutting-edge approaches could significantly advance CrcB research:

  • CRISPR-Cas9 Gene Editing:

    • Precise genome modifications for functional domain analysis

    • Creation of conditional expression systems

    • Generation of fluorescent protein fusions at endogenous loci

  • Advanced Imaging Techniques:

    • Super-resolution microscopy to visualize CrcB localization

    • Single-molecule tracking to observe dynamic behavior

    • Correlative light and electron microscopy for structural context

  • Systems Biology Integration:

    • Multi-omics approaches (transcriptomics, proteomics, metabolomics)

    • Network analysis of CrcB-associated pathways

    • Machine learning models to predict functional interactions

  • Realistic Model Systems:

    • Development of improved in vitro and in vivo models that better recapitulate the natural environmental conditions of C. violaceum

    • Implementation of microfluidic systems to mimic environmental transitions

    • 3D biofilm models to study CrcB function in community contexts

These approaches address the critical research gap identified in the literature: the need for realistic models that recapitulate the bacterial environment to enable comprehensive mechanistic studies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.